Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.

Coward WR, Watts K, Feghali-Bostwick CA, Jenkins G, Pang L.

Mol Cell Biol. 2010 Jun;30(12):2874-86. doi: 10.1128/MCB.01527-09. Epub 2010 Apr 19.

2.

Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.

Coward WR, Watts K, Feghali-Bostwick CA, Knox A, Pang L.

Mol Cell Biol. 2009 Aug;29(15):4325-39. doi: 10.1128/MCB.01776-08. Epub 2009 Jun 1.

3.

A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis.

Coward WR, Feghali-Bostwick CA, Jenkins G, Knox AJ, Pang L.

FASEB J. 2014 Jul;28(7):3183-96. doi: 10.1096/fj.13-241760. Epub 2014 Mar 20.

4.

E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.

Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.

Oncogene. 2006 Jan 12;25(2):230-9.

PMID:
16158053
5.

Epigenetic regulation of airway inflammation.

Adcock IM, Tsaprouni L, Bhavsar P, Ito K.

Curr Opin Immunol. 2007 Dec;19(6):694-700. Epub 2007 Aug 27. Review.

PMID:
17720468
6.

The role of histone deacetylases (HDACs) in human cancer.

Ropero S, Esteller M.

Mol Oncol. 2007 Jun;1(1):19-25. doi: 10.1016/j.molonc.2007.01.001. Epub 2007 Mar 7. Review.

7.

Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism.

Fang S, Miao J, Xiang L, Ponugoti B, Treuter E, Kemper JK.

Mol Cell Biol. 2007 Feb;27(4):1407-24. Epub 2006 Dec 4.

8.

Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.

Duan Z, Zarebski A, Montoya-Durango D, Grimes HL, Horwitz M.

Mol Cell Biol. 2005 Dec;25(23):10338-51.

10.

[The relationship between histone acetylation modification and IFN-gamma responsive gene regulation].

Guo JJ, Huang Y, Zhang J, Huang AL.

Zhonghua Gan Zang Bing Za Zhi. 2006 Jul;14(7):525-8. Chinese.

PMID:
16867276
11.

Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.

Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.

Mol Endocrinol. 2005 Jul;19(7):1740-51. Epub 2005 Mar 3.

PMID:
15746193
12.

Silencing of the Il2 gene transcription is regulated by epigenetic changes in anergic T cells.

Bandyopadhyay S, Montagna C, Macian F.

Eur J Immunol. 2012 Sep;42(9):2471-83. doi: 10.1002/eji.201142307. Epub 2012 Jul 13.

14.

Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone.

Ishii S, Yamada M, Satoh T, Monden T, Hashimoto K, Shibusawa N, Onigata K, Morikawa A, Mori M.

Mol Endocrinol. 2004 Jul;18(7):1708-20. Epub 2004 May 6.

PMID:
15131262
15.

Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.

Bhargavan B, Chhunchha B, Fatma N, Kubo E, Kumar A, Singh DP.

Epigenetics. 2013 Mar;8(3):268-80. doi: 10.4161/epi.23861. Epub 2013 Feb 5.

16.

Histone deacetylation is involved in activation of CXCL10 upon IFNgamma stimulation.

Guo JJ, Li QL, Zhang J, Huang AL.

Mol Cells. 2006 Oct 31;22(2):163-7.

17.

Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.

Liu JC, Baker RE, Chow W, Sun CK, Elsholtz HP.

Mol Endocrinol. 2005 Jul;19(7):1904-17. Epub 2005 Feb 24.

PMID:
15731170
18.

Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.

Huang SK, Scruggs AM, Donaghy J, Horowitz JC, Zaslona Z, Przybranowski S, White ES, Peters-Golden M.

Cell Death Dis. 2013 May 2;4:e621. doi: 10.1038/cddis.2013.146.

20.

Transcriptional repression of ER through hMAPK dependent histone deacetylation by class I HDACs.

Plotkin A, Volmar CH, Wahlestedt C, Ayad N, El-Ashry D.

Breast Cancer Res Treat. 2014 Sep;147(2):249-63. doi: 10.1007/s10549-014-3093-5. Epub 2014 Aug 17.

PMID:
25129342

Supplemental Content

Support Center